Clinical Trials Logo

Allergic Conjunctivitis clinical trials

View clinical trials related to Allergic Conjunctivitis.

Filter by:

NCT ID: NCT03660878 Completed - Clinical trials for Allergic Conjunctivitis

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis

Start date: September 8, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis.

NCT ID: NCT03627689 Terminated - Asthma Clinical Trials

Molekule for Allergic Rhinitis/Asthma

Start date: July 13, 2018
Phase: N/A
Study type: Interventional

Exposure to airborne allergens and pollutants is linked to symptom severity of allergies, asthma and other respiratory problems. In this study an air purifier using photo-electrochemical oxidation technology (PECO) will be used in the home environment of study participants. The investigator will assess the reduction of symptoms from allergic rhinitis/conjunctivitis and asthma.

NCT ID: NCT03494504 Completed - Clinical trials for Allergic Conjunctivitis

ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis

Start date: March 30, 2018
Phase: Phase 3
Study type: Interventional

A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions in Subjects with Acute Allergic Conjunctivitis

NCT ID: NCT03489941 Completed - Clinical trials for Allergic Conjunctivitis

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

Start date: April 7, 2018
Phase: Phase 3
Study type: Interventional

A Single-Center study to demonstrate the non-inferiority of EM-100 to Zaditor® in the treatment of ocular itching.

NCT ID: NCT03479307 Completed - Clinical trials for Allergic Conjunctivitis

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Start date: April 7, 2018
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of Bilastine ophthalmic solution 0.6% compared to vehicle and Zaditen (Ketotifen ophthalmic solution 0.025%) for the treatment of the signs and symptoms of allergic conjunctivitis.

NCT ID: NCT03368339 Completed - Clinical trials for Allergic Conjunctivitis

Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis

Start date: December 10, 2017
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of PR013 topical ophthalmic drops (0.045% and 0.06%) compared to vehicle for the treatment of the signs and symptoms of allergic conjunctivitis using a modified Conjunctival Allergen Challenge Model (Ora-CAC®).

NCT ID: NCT03320434 Completed - Clinical trials for Allergic Conjunctivitis

Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis

Start date: October 13, 2017
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of two concentrations of PRT-2761 as a topical ophthalmic solution for the treatment of the signs and symptoms of acute and chronic allergic conjunctivitis.

NCT ID: NCT03231969 Completed - Clinical trials for Allergic Conjunctivitis

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Start date: July 20, 2017
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of Bilastine Ophthalmic Solution (0.2%,0.4%,0.6%) compared to vehicle for the treatment of the signs and symptoms of allergic conjunctivitis

NCT ID: NCT03101618 Completed - Asthma Clinical Trials

Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers

Start date: August 24, 2016
Phase:
Study type: Observational

The investigators surveyed the prevalence of animal allergy and sensitization to animal allergen among participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and companion animal exhibition (pet owner and pet-related industry workers).

NCT ID: NCT03038971 Terminated - Allergic Rhinitis Clinical Trials

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Start date: March 30, 2017
Phase: Phase 1
Study type: Interventional

A safety study conducted on subjects ≥16 years old evaluating the safety of 4 intralymphatic injections of 2 different dose levels of the investigational short and tall ragweed product. Biomarkers will be assessed at baseline and at multiple time points post-treatment.